A major new study suggests that maintaining good vascular health could substantially reduce dementia risk before age 80.

New data suggest that up to 44% of new dementia cases may be attributed to poor vascular health in midlife and beyond.

Growth Hormone-Releasing Peptide-2 (GHRP-2) is a synthetic hexapeptide that has garnered significant attention in the ...

The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

A review summarizes how progranulin (PGRN) regulates lipid metabolism, dysregulation of which contributes to neurodegeneration. Hence, PGRN represents a promising therapeutic target for restoring ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish ...

During atherosclerosis, lipid-rich plaques are formed in large- and medium-sized arteries, which can reduce blood flow to tissues. This situation becomes particularly precarious when a plaque develops ...

Methods Two cardiac MRI cohorts were included: 2106 participants (median age: 65 years, 54% women) from the Multi-Ethnic Study of Atherosclerosis (MESA) and 2960 participants (median age: 64 years, 52 ...

Cardiomegaly describes the enlargement of the heart, and mild cardiomegaly generally refers to a slight enlargement that causes no symptoms. There are many different causes of mild cardiomegaly, ...